IL6 and obesity disorder: Butyrate, when administered in db/db diabetic mice with obesity via the I.P. route (1 g/kg), reduced the mRNA expression of inflammatory cytokines (interleukin 1, interleukin 6, and tumor necrosis factor α) in adipose tissue [47].